Key result
Multimodality RV imaging offers crucial prognostic value in pediatric pulmonary hypertension, but evidence remains limited.
Why the study?
Commonly used imaging modalities for RV assessment in pediatric pulmonary hypertension have distinct limitations, and prognostic thresholds are largely supported by level of evidence C, leaving persistent knowledge gaps.
Highlights the critical role and complementary strengths of echocardiography and CMR for RV assessment in pediatric pulmonary hypertension while outlining a roadmap to address current evidence gaps.
Caution advised applying current RV thresholds in pediatric PH; leaves open prospective validation of multimodality imaging parameters.
Right ventricular (RV) failure is a principal determinant of morbidity and mortality in children with pulmonary hypertension, making accurate RV assessment a cornerstone of risk stratification and long-term management. Noninvasive imaging plays a central role in this evaluation; however, commonly used modalities, including 2- and 3-dimensional echocardiography and cardiac magnetic resonance imaging, each have distinct advantages and limitations in the pediatric population. Consequently, an integrated, multimodal imaging strategy is required. This review provides a contemporary, critical appraisal of the existing evidence and key knowledge gaps related to noninvasive multimodality imaging of the RV in pediatric pulmonary hypertension. The discussion is structured around fundamental aspects of RV physiology, including chamber size and mass, systolic function, diastolic function and stiffness, RV-left ventricle interactions, ventriculoarterial coupling, and exercise assessment. Echocardiography and cardiac magnetic resonance imaging are presented in parallel to highlight their complementary roles within a multimodality framework. Current prognostic thresholds in pediatric pulmonary hypertension imaging are largely supported by level of evidence C, underscoring persistent gaps that limit the development of definitive clinical recommendations and a unified approach. We propose a roadmap to guide future research efforts and collaborative initiatives among pediatric pulmonary hypertension and imaging specialists, emphasizing the role of professional networks in advancing the field.
No takes yet. Share an insight, caveat, or question.
Miles et al. (2026) conducted a review in Pediatric pulmonary hypertension. Right ventricular multimodality imaging (Echocardiography and CMR) was evaluated. Noninvasive multimodality right ventricular imaging provides essential prognostic parameters in pediatric pulmonary hypertension, though most current thresholds are supported only by limited (Level C) evidence.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: